Bank & Trust Company’s GSK GSK Stock Holding History

Bank & Trust Company’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$98.5K	Sell	1,879 -182	-9%	-$9.63K	0.06%	135
2026 Q1	$114K	Hold	2,061	–	–	0.08%	127
2025 Q4	$101K	Buy	2,061 +1,789	+658%	+$83.4K	0.07%	127
2025 Q3	$11.7K	Hold	272	–	–	0.01%	219
2025 Q2	$10.4K	Sell	272 -40	-13%	-$1.53K	0.01%	224
2025 Q1	$12.1K	Hold	312	–	–	0.01%	217
2024 Q4	$10.6K	Hold	312	–	–	0.01%	223
2024 Q3	$12.8K	Hold	312	–	–	0.01%	210
2024 Q2	$12K	Buy	+312	New	+$13.1K	0.01%	217

Other funds holding GSK

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

MHI

Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.82B AUM

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

FVWA

Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return

Bank & Trust Company's GSK Position: Q2 2026 in Review

Bank & Trust Company reduced its GSK (GSK) stake by 8.8% in Q2 2026, selling an estimated $9.63K and leaving 1,879 shares worth $98.5K. The position accounts for 0.06% of the portfolio, ranked #135.

Bank & Trust Company first reported a position in GSK in Q2 2024 and has held it in 9 quarters since. The position peaked at $114K in Q1 2026. 439 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Bank & Trust Company held 1,879 shares of GSK worth $98.5K as of Q2 2026.
Bank & Trust Company sold 182 GSK shares in Q2 2026, an estimated $9.63K.
GSK made up 0.06% of Bank & Trust Company's portfolio in Q2 2026, its #135 holding.
Bank & Trust Company first reported a position in GSK in Q2 2024 and has held it in 9 quarters since.
Bank & Trust Company's GSK position peaked at $114K in Q1 2026.
439 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Bank & Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.